Page 4 - ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் Today - Breaking & Trending Today

Stanley Druckenmiller Says the Fed Is Endangering the Dollar's Global Reserve Status


The chairman and CEO of Duquesne Family Office said the Fed s insistence on holding interest rates down and buying trillions in bonds even though markets are thriving and the economy is booming is a long-term risk.
I can t find any period in history where monetary and fiscal policy were this out of step with the economic circumstances, not one, Druckenmiller said during a Squawk Box interview.
Though he does not take issue with the Fed s initial actions to combat the pandemic-related threats, Druckenmiller said the central bank has kept its foot on the accelerator too long.
He asserted that the Fed has continued its policies to help underwrite the spending binge in Congress, which has allocated more than $5 trillion in stimulus and is contemplating trillions more in infrastructure-related spending. ....

New York , United States , Jerome Powell , Christian Broda , Stanley Druckenmiller , William Dudley , Treasury Department , Federal Reserve , Duquesne Family Office , Wall Street Journal , New York Fed President William Dudley , Bloomberg News , Financial Stability Report , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஜெரோம் போவல் , கிறிஸ்துவர் ப்ரோடா , வில்லியம் டட்லி , கருவூலம் துறை , கூட்டாட்சியின் இருப்பு , ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் , சுவர் தெரு இதழ் , புதியது யார்க் ஊட்டி ப்ரெஸிடெஂட் வில்லியம் டட்லி , ப்ளூம்பெர்க் செய்தி , நிதி ஸ்திரத்தன்மை அறிக்கை ,

Cancer surveillance co C2i Genomics raises $100m


Cancer surveillance co C2i Genomics raises $100m
The company s cancer diagnostics service uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease.
Cancer surveillance company C2i Genomics has announced the completion of a $100 million financing round led by Casdin Capital with participation from NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others.
The funding will accelerate clinical development and commercialization of the company’s C2-Intelligence Platform, a cancer diagnostics service that uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease that is up to 100 times more sensitive than competing technologies. ....

Asaf Zviran , Langone Health , Aarhus University Hospital , Lausanne University Hospital , Duquesne Family Office , National Cancer Centre Singapore , Casdin Capital , Globe Partners , Driehaus Capital , Intelligence Platform , லன்கொனே ஆரோக்கியம் , ஆர்ஹஸ் பல்கலைக்கழகம் மருத்துவமனை , ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் , தேசிய புற்றுநோய் மையம் சிங்கப்பூர் , பூகோளம் கூட்டாளர்கள் , உளவுத்துறை நடைமேடை ,

The 50 Most Promising Israeli Startups - 2021

The 50 Most Promising Israeli Startups - 2021
calcalistech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from calcalistech.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Israel General , Al Jizah , Distrito Federal , Beer Sheva , Hong Kong , United Kingdom , Tel Aviv , Ha Afon , City Of , Green Oaks , Itzik Elbaz , Itai Zlotnik , Tarik Sultan , Gal Oron , Hannan Saltzman , Tom Glocer , Tommy Harpaz , Roey Izkovsky , Rotem Alaluf , Roey Mechraz , Gal Ben David , Ira Belsky , Ehud Weinstein , Assaf Ayalon ,

C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform -


– Funds will be used to accelerate clinical development and commercialization of the company’s C2-Intelligence Platform, a cancer diagnostics service, that uses AI pattern recognition and whole-genome analysis to provide rapid and cancer-specific detection of residual disease 100x more sensitive than legacy platforms.
– C2i Genomics also plans to use financing to strengthen partnerships with pharmaceutical companies and accelerate development of novel oncology drugs and pursue regulatory and reimbursement approvals in the US and Europe. 
– C2i Genomics received its $12M Series A round of funding in June 2020.
C2i Genomics, is an AI and genomics startup, founded in 2019 and led by executives from Bristol-Myers Squibb, GSK, Tempus, Foundation Medicine and Thrive Earlier Detection. The cloud-based platform was created to help labs provide deeper insights and subtle changes in cancer burden, and gives patients and physicians alike more precise knowledge of next st ....

Bristol Myers Squibb , Foundation Medicine , Duquesne Family Office , Genomics Raises , Whole Genome Cancer Treatment Intelligence , Casdin Capital , Globe Partners , Driehaus Capital , Intelligence Platform , Thrive Earlier , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , அடித்தளம் மருந்து , ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் , பூகோளம் கூட்டாளர்கள் , உளவுத்துறை நடைமேடை , செழித்து வளருங்கள் முந்தைய ,